{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:00:27Z","timestamp":1793437227540,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Ventricular tachycardia\/ventricular fibrillation (VT\/VF) is a kind of malignant arrhythmia in ST-segment elevation myocardial infarction (STEMI) patients who received primary percutaneous coronary intervention (PPCI). However, there are no risk assessment tools to anticipate the occurrence of VT\/VF.<\/jats:p>\n            <jats:p>This study is to build a risk assessment model to predict the possibility of VT\/VF onset in STEMI patients undergoing PPCI.<\/jats:p>\n            <jats:p>A retrospective study was conducted to analyze the patients who underwent PPCI from January 2006 to May 2015. Subjects were divided into VT\/VF group and no VT\/VF group based on whether VT\/VF had occurred or not. In addition, the VT\/VF group was further separated into early-onset group (from the time that symptoms began to before the end of PPCI) and late-onset group (after the end of PPCI) based on the timing of when VT\/VF happened. Multivariate regression analysis was carried out to distinguish the independent risk factors of VT\/VF and an additional statistical method was executed to build the risk assessment model.<\/jats:p>\n            <jats:p>A total of 607 patients were enrolled in this study. Of these patients, 67 cases (11%) experienced VT\/VF. In addition, 91% (61) of patients experienced VT\/VF within 48\u200ah from the time that the symptoms emerged. Independent risk factors include: age, diabetes mellitus, heart rate, ST-segment maximum elevation, ST-segment total elevation, serum potassium, left ventricular ejection fraction (LVEF), culprit artery was right coronary artery, left main (LM) stenosis, Killip class &gt; I class, and pre-procedure thrombolysis in myocardial infarction (TIMI) flow zero grade. Risk score model and risk rank model have been established to evaluate the possibility of VT\/VF. Class I: \u2264 4 points; Class II: &gt; 4 points, \u2264 5.5 points; Class III: &gt; 5.5 points, &lt; 6.5 points; and Class IV \u2265 6.5 points. The higher the class, the higher the risk.<\/jats:p>\n            <jats:p>The incidence of VT\/VF in STEMI patients undergoing PPCI is 11% and it occurs more frequently from the time that symptoms begin to before the end of PPCI, which, in most cases, occurs within 48\u200ah of the event. Our risk assessment model could predict the possible occurrence of VT\/VF.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014174","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T07:15:32Z","timestamp":1548400532000},"page":"e14174","source":"Crossref","is-referenced-by-count":12,"title":["Risk assessment model for predicting ventricular tachycardia or ventricular fibrillation in ST-segment elevation myocardial infarction patients who received primary percutaneous coronary intervention"],"prefix":"10.1097","volume":"98","author":[{"given":"Jiabing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1161\/01.CIR.0000065223.21530.11","article-title":"Prospective study of sudden cardiac death among women in the United States","volume":"107","author":"Albert","year":"2003","journal-title":"Circulation"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/CIRCULATIONAHA.111.023846","article-title":"Sudden cardiac death caused by coronary heart disease","volume":"125","author":"Myerburg","year":"2012","journal-title":"Circulation"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0002-9149(88)90921-6","article-title":"Usefulness of the accelerated idioventricular rhythm as a marker for myocardial necrosis and reperfusion during thrombolytic therapy in acute myocardial infarction","volume":"61","author":"Gorgels","year":"1988","journal-title":"Am J Cardiol"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/0002-9149(91)90184-M","article-title":"Time course and interrelation of reperfusion-induced ST changes and ventricular arrhythmias in acute myocardial infarction","volume":"68","author":"Zehender","year":"1991","journal-title":"Am J Cardiol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0002-9149(92)91295-F","article-title":"Holter recording of ventricular arrhythmias during intravenous thrombolysis for acute myocardial infarction","volume":"69","author":"Gressin","year":"1992","journal-title":"Am J Cardiol"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/0735-1097(93)90756-Q","article-title":"Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial","volume":"22","author":"Berger","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.CIR.98.23.2567","article-title":"Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators","volume":"98","author":"Newby","year":"1998","journal-title":"Circulation"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2003.09.072","article-title":"Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes","volume":"43","author":"Mehta","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ahj.2011.01.005","article-title":"Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk","volume":"161","author":"Mehta","year":"2011","journal-title":"Am Heart J"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"e001399","DOI":"10.1161\/JAHA.114.001399","article-title":"Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark","volume":"4","author":"Jabbari","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.hrthm.2010.11.046","article-title":"Effect of reperfusion time on inducible ventricular tachycardia early and spontaneous ventricular arrhythmias late after ST elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"8","author":"Kumar","year":"2011","journal-title":"Heart Rhythm"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.amjcard.2015.12.002","article-title":"Long-term outcomes in survivors of early ventricular arrhythmias after acute ST-elevation and non-ST-elevation myocardial infarction treated with percutaneous coronary intervention","volume":"117","author":"Liang","year":"2016","journal-title":"Am J Cardiol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/2048872614547448","article-title":"Impact of out-of-hospital cardiac arrest due to ventricular fibrillation in patients with ST-elevation myocardial infarction admitted for primary percutaneous coronary intervention: Impact of ventricular fibrillation in STEMI patients","volume":"4","author":"Demirel","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.amjcard.2014.11.025","article-title":"Predictors of ventricular fibrillation at reperfusion in patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention","volume":"115","author":"Demidova","year":"2015","journal-title":"Am J Cardiol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2011.10.043","article-title":"Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial)","volume":"109","author":"Mehta","year":"2012","journal-title":"Am J Cardiol"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1001\/jama.2009.600","article-title":"Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention","volume":"301","author":"Mehta","year":"2009","journal-title":"JAMA"},{"key":"R17-20230914","first-page":"e78","article-title":"2013\u200aACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"American College of Emergency, P., Society for Cardiovascular, A., Interventions","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.CIR.87.2.312","article-title":"Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results","volume":"87","author":"Maggioni","year":"1993","journal-title":"Circulation"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/CIRCRESAHA.116.304521","article-title":"The spectrum of epidemiology underlying sudden cardiac death","volume":"116","author":"Hayashi","year":"2015","journal-title":"Circ Res"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/hrt.50.6.525","article-title":"Hypokalaemia and ventricular fibrillation in acute myocardial infarction","volume":"50","author":"Nordrehaug","year":"1983","journal-title":"Br Heart J"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.bjp.0707673","article-title":"Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents","volume":"153","author":"Heusch","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.hrthm.2014.11.034","article-title":"Prolonged Tpeak-end and Tpeak-end\/QT ratio as predictors of malignant ventricular arrhythmias in the acute phase of ST-segment elevation myocardial infarction: a prospective case-control study","volume":"12","author":"Shenthar","year":"2015","journal-title":"Heart Rhythm"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0002-9149(88)91060-0","article-title":"Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarcts","volume":"61","author":"Aldrich","year":"1988","journal-title":"Am J Cardiol"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/pmj.79.935.490","article-title":"The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis","volume":"79","author":"Birnbaum","year":"2003","journal-title":"Postgrad Med J"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amjcard.2014.12.008","article-title":"Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial)","volume":"115","author":"Dohi","year":"2015","journal-title":"Am J Cardiol"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0735-1097(03)00713-7","article-title":"Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance","volume":"42","author":"Yan","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.amjcard.2006.07.033","article-title":"Long-term survival after right ventricular infarction","volume":"98","author":"Gumina","year":"2006","journal-title":"Am J Cardiol"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1161\/01.CIR.88.6.2903","article-title":"Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia. Role of the transient outward current","volume":"88","author":"Lukas","year":"1993","journal-title":"Circulation"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/CIRCULATIONAHA.112.000491","article-title":"Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study","volume":"128","author":"Marijon","year":"2013","journal-title":"Circulation"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/2013.jamainternmed.744","article-title":"Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study","volume":"173","author":"Chen","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/0002-9149(84)90100-0","article-title":"Correlates of reperfusion ventricular fibrillation in dogs","volume":"53","author":"Hale","year":"1984","journal-title":"Am J Cardiol"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/0735-1097(89)90418-X","article-title":"Sudden paradoxic clinical deterioration during angioplasty of the occluded right coronary artery in acute myocardial infarction","volume":"14","author":"Gacioch","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jacc.2007.08.061","article-title":"Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction","volume":"51","author":"Gibson","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","article-title":"Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial","volume":"128","author":"Ibanez","year":"2013","journal-title":"Circulation"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.jacc.2016.03.522","article-title":"Early intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention","volume":"67","author":"Roolvink","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R37-20230914","article-title":"2017\u200aAHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","author":"Al-Khatib","year":"2017","journal-title":"Heart Rhythm"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/FJC.0b013e3181d64dde","article-title":"Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention","volume":"55","author":"Das","year":"2010","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:27:46Z","timestamp":1694716066000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014174","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}